TITLE

Levonorgestrel Intrauterine Device Use in Overweight and Obese Women

AUTHOR(S)
Saito-Tom, Lynne Y.; Soon, Reni A.; Harris, Sara C.; Salcedo, Jennifer; Kaneshiro, Bliss E.
PUB. DATE
November 2015
SOURCE
Hawaii Journal of Medicine & Public Health;Nov2015, Vol. 74 Issue 11, p369
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The levonorgestrel intrauterine device (LNG-IUD) is a safe, effective, long-acting, reversible contraceptive that reduces unintended pregnancy and decreases heavy menstrual bleeding. Many procedures such as IUD insertion are more challenging in overweight and obese women. The objective of this study was to describe LNG-IUD insertion, continuation, and complications in overweight and obese women in an ethnically diverse population in Hawai'i. A retrospective cohort study of women who had a LNG-IUD inserted at the University of Hawai'i, Department of Obstetrics and Gynecology Resident and Faculty practice sites between January 2009 and December 2010 was performed. A total of 149 women were followed. The most commonly reported races were Asian (32%), Native Hawaiian (26%), and non-Hawaiian Pacific Islander (20%). The mean BMI of the study population was 28.4 (standard deviation 7.2) with 37% classified as normal weight, 30% as overweight, and 33% as obese. Overall, 76% of women continued the LNG-IUD 12 months after insertion. No statistically significant difference emerged in 12-month IUD continuation between the BMI groups. Difficult (5%) and failed (3%) IUD insertions were rare for all BMI groups. IUD complications occurred in 9% of women and included expulsion and self-removal. In this diverse population, the majority of women continued to use the LNG-IUD one year after insertion with low rates of difficult insertions and complications.
ACCESSION #
110629990

 

Related Articles

  • Ectopic pregnancy following levonorgestrel emergency contraception: a case report.  // Journal of the Turkish-German Gynecological Association;Sep2010, Vol. 11 Issue 3, p168 

    No abstract available.

  • Long-acting reversible contraception. Wilkes, Scott // British Journal of General Practice;Sep2013, Vol. 63 Issue 614, p463 

    The article presents the author's comments about the levonorgestrel-releasing intrauterine system that was published in the "Journal of Family Planning and Reproductive Healthcare."

  • EMERGENCY CONTRACEPTION: A LAST CHANCE TO PREVENT UNINTENDED PREGNANCY. TRUSSELL, JAMES; RAYMOND, ELIZABETH G.; CLELAND, KELLY // Contemporary Readings in Law & Social Justice;2014, Vol. 6 Issue 2, p7 

    Emergency contraception provides women with a last chance to prevent unintended pregnancy after sex. In the United States, available options for emergency contraception are three kinds of pills (levonorgestrel, ulipristal acetate, and regular oral contraceptive pills in different doses) and the...

  • Anticoncepción intrauterina en nulíparas: de las percepciones a las evidencias. Estudio comparativo entre médicos latinoamericanos. Lira-Plascencia, J.; Marín-Cantú, V. A.; Bahamondes, L.; Martín, O. R.; Kosoy, G. J. // Ginecologia y Obstetricia de Mexico;jul2016, Vol. 84 Issue 7, p403 

    OBJECTIVE: To identify the perception of Latin American doctors about the knowledge, use, motivators and obstacles related to the use of intrauterine contraceptives, particularly in nulliparous women. MATERIAL AND METHOD: Prospective study type survey via internet directed to gynecologists or...

  • Emergency contraception -- Keep it simple. Creinin, Mitchell D. // Journal of Family Practice;Apr2007 Supplement, Vol. 56, p8 

    The article provides information on levonorgestrel (LNG) method or Plan B, the only method of emergency contraception (EC) approved by the U.S. Food and Drug Administration (FDA) to provide protection against unwanted pregnancy in the U.S. Plan B (LNG tablets 0.75 milligrams) is available to...

  • Improving access to emergency contraception.  // BMJ: British Medical Journal (International Edition);01/27/2001, Vol. 322 Issue 7280, p186 

    Editorial. Reports on the decision in the United Kingdom to allow pharmacists to supply progestogen-only emergency contraception without a prescription, as of January 1, 2001. Development of a product containing levonorgestrel (Levonelle) will be available for women over 16-years of age;...

  • Unintended and unwanted pregnancy in Australia: a cross-sectional, national random telephone survey of prevalence and outcomes. Yeates, Sophie L; Elder, Charlotte V; Grover, Sonia R // Medical Journal of Australia;May2019, Vol. 210 Issue 8, p382 

    The article offers information on the 309 women, who underwent terminations for unwanted pregnancy from January 2016 to October 2018. It mentions from 309 women, 145 chose surgical termination and 164 women chose medical termination. Compared with the national survey; and also mentions most...

  • New review focuses on emergency contraception. Long, Abigail; Jordan, Beth // Contraceptive Technology Update;Aug2008, Vol. 29 Issue 8, p90 

    A new review of clinical trial results indicates mifepristone is the most effective emergency contraceptive (EC); however, the drug isn't approved in the United States for this use. ∎ Most of the trials studied mifepristone in two levels: low dose and middle dose. Levonorgestrel trials...

  • Emergency contraception. Newson, Louise // GP: General Practitioner;9/8/2006, p46 

    The article presents information related to emergency hormonal contraception. It is a safe, cheap and highly effective way of preventing an accidental pregnancy. Appropriate use of emergency contraception could prevent up to 75 percent of unplanned pregnancies. A single dose of levonorgestrel...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics